Company: MNTR
Filing Date: 2025-08-13
Form Type: 10-Q
Source: 0001493152-25-011889
Chunk: 35

Company: Mentor Capital, Inc.
Filing Date: 2025-08-13
Form: 10-Q
Item: Item 1
Chunk 35
---
 merger with a cancer development company. In conjunction with those related
agreements, the Company issued 689,159 Series H ($7) Warrants, with a 30-year life. As of June 30, 2025, and December 31, 2024, there
were 413,512 Series H ($7) Warrants outstanding. The warrants are subject to cashless exercise based upon the ten-day trailing closing
bid price preceding the exercise as interpreted by the Company.

As
of June 30, 2025, and December 31, 2024, the weighted average contractual life for all Mentor warrants was 13.00 years and 13.50 years,
respectively, and the weighted average outstanding warrant exercise price was $0.64 and $0.64 per share, respectively.

During
the six months ended June 30, 2025, no Series D warrants were exercised, and no warrants were issued. The intrinsic value of outstanding
warrants at June 30, 2025 and December 31, 2024 was $110,500 and $237,150, respectively.

The
following table summarizes Series D common stock warrants as of each period:

 Schedule of common stock warrants 

    Series D 
  
    Outstanding at December 31, 2023 
     6,250,000 
  
    Issued 
     - 
  
    Canceled 

    Exercised 
     2,000,000 

    Outstanding at December 31, 2024 
     4,250,000 
  
    Issued 
     - 
  
    Exercised 
     - 
  
    Outstanding at June 30, 2025 
     4,250,000 

    -25-

Series
E, F, G, and H warrants were issued for investment banking and advisory services during 2009. Series E, F, and G warrants were exercised
in 2014. As of June 30, 2025, there were 413,512 Series H ($7) Warrants outstanding. The following table summarizes Series H ($7) warrants
as of each period:

    Series H $7.00 exercise price 
  
    Outstanding at December 31, 2023 
     413,512 
  
    Issued 
     - 
  
    Canceled 
     - 
  
    Exercised 
     - 
  
    Outstanding at